| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w23760 |
| 来源ID | Working Paper 23760 |
| Public Insurance and Psychotropic Prescription Medications for Mental Illness | |
| Johanna Catherine Maclean; Benjamin L. Cook; Nicholas Carson; Michael F. Pesko | |
| 发表日期 | 2017-09-04 |
| 出版年 | 2017 |
| 语种 | 英语 |
| 摘要 | Mental illnesses are prevalent in the United States and globally. Cost is a critical barrier to treatment receipt. We study the effects of recent and major eligibility expansions within Medicaid, a public insurance system for the poor in the U.S., on psychotropic prescription medications for mental illness. We estimate differences-in-differences models using administrative data on medications for which Medicaid was a third-party payer over the period 2011 to 2017. Our findings suggest that these expansions increased psychotropic prescriptions by 22.3%. We show that Medicaid, and not patients, financed these prescriptions. For states expanding Medicaid, the total cost of these prescriptions was $30.8M. Expansion effects were experienced across most major mental illness categories and across states with different levels of patient need, system capacity, and expansion scope. We find no evidence that Medicaid expansion reduced a proxy for serious mental illness: suicide. |
| 主题 | Health, Education, and Welfare ; Health |
| URL | https://www.nber.org/papers/w23760 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/581434 |
| 推荐引用方式 GB/T 7714 | Johanna Catherine Maclean,Benjamin L. Cook,Nicholas Carson,et al. Public Insurance and Psychotropic Prescription Medications for Mental Illness. 2017. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w23760.pdf（328KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
